Advertisement

Topics

Companies Related to "Pharma Supports 10th Annual Rare Disease Joins Global" [Most Relevant Company Matches] RSS

02:08 EDT 20th June 2018 | BioPortfolio

Here are the most relevant search results for "Pharma Supports 10th Annual Rare Disease Joins Global" found in our extensive corporate database of over 50,000 company records.

Showing "Pharma Supports 10th Annual Rare Disease Joins Global" Companies 1–25 of 7,900+

Extremely Relevant

Global Genes

Global Genes is a non-profit organization that operates as one of the leading rare disease patient advocacy groups in the world. Global Genes promotes the needs of the Rare Disease Community under a unifying symbol of hope—the Blue Denim Genes Ribbon™. The organization was born out of humble beginnings, emerging as a grassroots movement in 2009 comprise...


Relevant

Children's Rare Disease Network

The Children's Rare Disease Network (CDRN) is a non-profit advocacy group committed to connecting, educating and empowering the rare disease community, providing a link between families impacted by rare disease. The CDRN is a division of and developed by The R.A.R.E. Project which exists to promote rare disease advocacy, research and accelerated therapy development. For more information, visit w...

Rare Disease Communications®

Rare Disease Communications® is a health care communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients will be diagnosed and treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates, Inc. family of businesses, ...


The Global Genes Project

The Global Genes Project is a campaign of the Children's Rare Disease Network and is a grassroots effort with the goal to increase awareness about the prevalence of rare diseases worldwide. The Children's Rare Disease Network is a registered 501c3 non profit organization. For more information, visit http://www.crdnetwork.org.

Rare Disease Communications

Rare Disease Communications® is a healthcare communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so that patients will be diagnosed and treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates, Inc. family of businesses, ...

TargetCancer

TargetCancer promotes the development of lifesaving treatment protocols for rare cancers. Through fundraising, outreach, and advocacy, TargetCancer supports those living with rare cancers and funds research initiatives at the forefront of cancer treatment – efforts that treat the individual as well as the disease.

National Organization for Rare Disorders

Mission StatementThe National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. W...

SLA Pharma AG

S.L.A. Pharma AG is a privately owned Swiss company pioneering the development of speciality pharmaceutical products for gastrointestinal and rare disorders. Their pipeline consists of Phase II and Phase III developments for indications with unmet clinical needs such as anal fissure, symptoms of Crohn’s disease, opioid induced constipation, familial a...

Biotechnology Industry Organization (BIO) and National Organization for Rare Disorders (NORD)

The National Organization for Rare Disorders (NORD), established in 1983, is the leading, independent nonprofit organization dedicated to helping all patients and families affected by rare diseases in the U.S. NORD is committed to the identification, treatment and cure of all 7,000 rare diseases, which affect 30 million Americans, or 1 in every 10 people. ...

Food Addicts in Recovery Anonymous

In one year, the number of Food Addicts in Recovery Anonymous (FA) meetings throughout the world has increased more than 15 percent, reported the 12-Step recovery program hosting its 10th annual business convention.

BioPontis Alliance LLC

BioPontis Alliance for Rare Disease is a North Carolina non-profit corporation that partners with patient organizations and academic researchers to carry out the earliest stages of product development to bridge the gap between ideas for treatments and drug compounds that are ready for uptake by the biopharmaceutical and biotech industry. BioPontis Alliance...

Guthy-Jackson Charitable Foundation

The Guthy-Jackson Charitable Foundation is dedicated to funding basic science research to find answers that will lead to the prevention, clinical treatments and an eventual cure for Neuromyelitis Optica (NMO) Spectrum Disease (also known as Devic’s Disease), a rare neurological disease that is often misdiagnosed as Multiple Sclerosis (MS). Found...

The Guthy-Jackson Charitable Foundation

The Guthy-Jackson Charitable Foundation is dedicated to funding basic science research to find answers that will lead to the prevention, clinical treatments and an eventual cure for Neuromyelitis Optica (NMO) Spectrum Disease (also known as Devic’s Disease), a rare neurological disease that is often misdiagnosed as Multiple Sclerosis (MS). Found...

Xenon Pharmaceuticals Inc

Xenon is a privately held company located in Vancouver and has just over 70 employees. We are a leader in clinical genetic based drug discovery and development and have built a worldwide network of over 40 clinical collaborators to find and access the rare families with diseases of relevance to drug discovery. Our clinical genetic approaches are: Extreme Genetics TM: the analysis of rare families ...

Rare Genomics Institute

RG is an international 501(c) 3 non-profit that makes cutting edge research technologies of genome sequencing, physicians and scientists around the world accessible to rare disease patients. For more information, visit http://www.raregenomics.org.

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemo...

Astellas Pharma Global Development

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstand...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more than 100 years of history as an independent, research-based specialty pharmaceutical company.

SK group

SK group, serving the pharma industry with dedication since 1932, has a proven track record and expertise in manufacturing, importing, exporting & distribution of Bulk Drugs, Fine Chemicals and Pharma Formulations.In addition, the SK Group exports surgicals, hospital requisites, medical equipments, pharma machineries, packing materials, electrical items and building materials into several countrie...

Speid & Associates, Inc.

Speid & Associates, Inc. provides global regulatory affairs and drug development consulting services to the pharma and biotech industries. The goal of the company is to expedite access of patients to novel therapeutics, particularly for rare diseases, orphan indications, and unmet medical needs.

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. FranceMed Pharma is certified to ISO 9001 and ISO 13485.

Orphan Europe (UK) Ltd.

Orphan Europe was started with the objective of providing orphan drugs to patients afflicted by rare disorders.Over the years an information network has been established to increase the awareness about rare disorders among healthcare professionals. The company has committed itself to provide support necessary to those working in this field. This is achieved through an extensive collaboration with ...

AVROBIO, Inc.

AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical-stage company developing disruptive therapies that have the potential to transform patients’ lives with a single dose. The Company is focused on the development of its Phase 1 program in Fabry disease and pre-Phase 1/2 program in Gaucher disease, while actively building a pipeli...

Inozyme Pharma, Inc.

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcification of soft tissues and under mineralization of bone. The company was founded in 2016 with technology licensed from Yale University.

Strongbridge Biopharma plc

Following the successful completion of its exchange offer to acquire the issued ordinary shares of Cortendo AB, Strongbridge Biopharma is now the new parent company of the Cortendo group. The group’s strategic focus is to build a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complemen...


More From BioPortfolio on "Pharma Supports 10th Annual Rare Disease Joins Global"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks